One Medical’s $2.1 billion buy up of Iora came as a bit of a shock this week. It’s not the first acquisition I would have expected from One Medical, although in hindsight I can totally understand the rationale.
To get a perspective on the news, I reached out to Malay Gandhi for an authentic take. If you don’t already know him personally, Malay is an OG digital health strategist and thinker. He’s formerly of Evidation and Rock Health - and is now with Benchling.
So thanks Malay!
I’ll note, given my journalistic background, that this is one person’s perspective. For the companies’ statements on the acquisition, read the news release here. Malay’s thoughts below:
CF: Were you surprised by this acquisition or did you expect it?
MG: On some level every acquisition is a “surprise” but looking at it in post, there’s a clear story and deal rationale, so it’s not terribly surprising. One Medical and Iora as a combined entity address nearly every segment and distribution model in primary care. Oak…